Page last updated: 2024-10-21

4-amino-1,8-naphthalimide and Encephalitis

4-amino-1,8-naphthalimide has been researched along with Encephalitis in 1 studies

4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;

Encephalitis: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komirishetty, P1
Areti, A1
Gogoi, R1
Sistla, R1
Kumar, A1

Other Studies

1 other study available for 4-amino-1,8-naphthalimide and Encephalitis

ArticleYear
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
    Neuropharmacology, 2017, Volume: 113, Issue:Pt A

    Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mi

2017